The U.S. Department of Health and Human Services (HHS) has officially announced the allocation of $77 million in new grant funding aimed at strengthening the nation’s behavioral health infrastructure. Distributed through the Substance Abuse and Mental Health Services Administration (SAMHSA), these funds are designated for a comprehensive suite of services, including substance use prevention, addiction […]
The clinical landscape for glaucoma management is currently defined by a stark paradox: while surgical interventions have become increasingly sophisticated, the success of these procedures remains heavily dependent on a grueling, patient-led post-operative regimen that often borders on the unmanageable. For those suffering from glaucoma—a leading cause of irreversible blindness worldwide—the most daunting aspect of […]
Forus, a pioneering artificial intelligence platform dedicated to streamlining the delivery of modern medicine, announced on Tuesday that it has successfully raised $150 million in a Series C funding round. This latest capital infusion brings the company’s total valuation to a staggering $3 billion, marking its transition into one of the most significant "unicorns" in […]
Radiology serves as the indispensable nexus of modern clinical medicine, functioning as the primary bridge between the presentation of symptoms and the implementation of life-saving treatment protocols. In the current global healthcare landscape, diagnostic imaging has become the bedrock of patient care, with an estimated 3.6 billion exams performed annually. In the United States alone, […]
The healthcare industry has reached a pivotal crossroads where the integration of artificial intelligence (AI) is no longer a prospective goal but a functional reality. According to the 2026 Healthcare AI Readiness Index, a comprehensive study co-authored by Cotiviti and MedCity News, the primary challenge facing the sector has shifted from initial adoption to the […]
Energy and Commerce Committee Ranking Member Frank Pallone, Jr. (D-New Jersey) has formally initiated a sweeping oversight investigation into the entities responsible for adjudicating payment disputes under the No Surprises Act, signaling a major escalation in congressional efforts to curb rising healthcare costs. On Thursday, Pallone dispatched detailed oversight letters to six prominent independent dispute […]
GSK has significantly expanded its oncology pipeline through a strategic licensing agreement with Hutchmed (China) Limited, securing the global rights—excluding Greater China—to a pioneering cancer treatment that utilizes a dual-action mechanism to combat solid tumors. Under the terms of the agreement announced on September 3, GSK will provide an upfront payment of $110 million to […]
Heart disease remains the leading cause of death among women in the United States, yet the medical community continues to struggle with a persistent cycle of underrecognition, underdiagnosis, and undertreatment within this demographic. Despite decades of advocacy and public health campaigns, recent data suggests that the cardiovascular health of American women is not only failing […]
The modern American healthcare landscape is defined not only by the clinical quality of its services but also by a pervasive sense of financial apprehension that precedes the delivery of care. For millions of patients, the primary barrier to accessing medical services is no longer just the absolute price of a procedure, but the "paralyzing […]
SK Biopharmaceuticals, a prominent South Korean pharmaceutical entity with an established presence in the United States, has finalized a definitive agreement to in-license the global rights for opakalim, a late-stage clinical drug candidate targeting focal onset epilepsy. The deal, valued at up to $795 million including milestones, represents a significant strategic pivot for the Seoul-based […]
